高效抗逆转录病毒治疗时代的残余HIV-1疾病 - Suppr

Suppr

超能文献

Residual HIV-1 disease in the era of highly active antiretroviral therapy.

作者信息

Pomerantz R J

出版信息

N Engl J Med. 1999 May 27;340(21):1672-4. doi: 10.1056/NEJM199905273402110.

DOI:10.1056/NEJM199905273402110

PMID:10341281

Abstract

摘要

相似文献

Residual HIV-1 disease in the era of highly active antiretroviral therapy.

N Engl J Med. 1999 May 27;340(21):1672-4. doi: 10.1056/NEJM199905273402110.

Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.

N Engl J Med. 1999 May 27;340(21):1614-22. doi: 10.1056/NEJM199905273402102.

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

N Engl J Med. 1999 May 27;340(21):1605-13. doi: 10.1056/NEJM199905273402101.

Antiretroviral resistance.

J HIV Ther. 2006 Dec;11(4):72-3.

[Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects].

Pathologica. 2000 Aug;92(4):291-3.

Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.

N Engl J Med. 1998 Dec 17;339(25):1803-9. doi: 10.1056/NEJM199812173392502.

HIV-1 DNA and RNA kinetics in primary HIV infection.

J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):49-52.

[Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA].

Medicina (B Aires). 2004;64(5):419-28.

Different patterns of HIV-1 DNA after therapy discontinuation.

BMC Infect Dis. 2005 Sep 12;5:69. doi: 10.1186/1471-2334-5-69.

[Highly active initial therapy without resistance development. Even after 6 years still effective HIV therapy].

MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:54-5.

引用本文的文献

Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.

BMC Res Notes. 2014 Jan 21;7:52. doi: 10.1186/1756-0500-7-52.

Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.

Retrovirology. 2007 Aug 8;4:56. doi: 10.1186/1742-4690-4-56.

Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients.

J Neurovirol. 2006 Apr;12(2):100-7. doi: 10.1080/13550280600713932.

In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months.

J Virol. 2003 Feb;77(3):2271-5. doi: 10.1128/jvi.77.3.2271-2275.2003.

Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients.

Antimicrob Agents Chemother. 2003 Jan;47(1):238-43. doi: 10.1128/AAC.47.1.238-243.2003.

Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.

J Virol. 2002 Oct;76(20):10099-108. doi: 10.1128/jvi.76.20.10099-10108.2002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验